{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:35:52Z","timestamp":1793979352463,"version":"4.8.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00428-024-03972-9","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T22:40:28Z","timestamp":1739486428000},"page":"1161-1166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mesonephric-like adenocarcinoma of the endometrium: detailed molecular characterization of the first case showing a morphological continuum from mesonephric-like metaplasia and atypical mesonephric-like hyperplasia to adenocarcinoma"],"prefix":"10.1007","volume":"487","author":[{"given":"Angela","family":"Santoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Angelico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Narducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Travaglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Piermattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frediano","family":"Inzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Arciuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Addante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen Padial","family":"Urtueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giordana","family":"Tinnirello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"D\u2019Alessandris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Minucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4473-7560","authenticated-orcid":false,"given":"Gian Franco","family":"Zannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"3972_CR1","unstructured":"WHO Classification of tumours editorial board (2020) Female genital tumours. In WHO classification of tumours.\u00a05th ed.\u00a0Lyon, France: International Agency for Research on Cancer"},{"key":"3972_CR2","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.3390\/cancers13112623","volume":"13","author":"A Santoro","year":"2021","unstructured":"Santoro A, Angelico G, Travaglino A, Inzani F, Arciuolo D, Valente M, D\u2019Alessandris N, Scaglione G, Fiorentino V, Raffone A, Zannoni GF (2021) New pathological and clinical insights in endometrial cancer in view of the updated ESGO\/ESTRO\/ESP guidelines. Cancers (Basel) 13:2623","journal-title":"Cancers (Basel)"},{"key":"3972_CR3","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/his.14892","volume":"82","author":"J Mirkovic","year":"2023","unstructured":"Mirkovic J, Olkhov-Mitsel E, Amemiya Y, Al-Hussaini M, Nofech-Mozes S, Djordjevic B, Kupets R, Seth A, McCluggage WG (2023) Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas. Histopathology 82:978\u2013990","journal-title":"Histopathology"},{"key":"3972_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","volume":"36","author":"SL Kenny","year":"2012","unstructured":"Kenny SL, McBride HA, Jamison J, McCluggage WG (2012) Mesonephric adenocarcinomas of the uterine cervix and corpus: Hpv-negative neoplasms that are commonly pax8, ca125, and hmga2 positive and that may be immunoreactive with ttf1 and hepatocyte nuclear factor 1-beta. Am J Surg Pathol 36:799\u2013807","journal-title":"Am J Surg Pathol"},{"key":"3972_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PAS.0000000000000991","volume":"43","author":"K Na","year":"2019","unstructured":"Na K, Kim HS (2019) Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body. Am J Surg Pathol 43:12\u201325","journal-title":"Am J Surg Pathol"},{"key":"3972_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/PGP.0000000000000102","volume":"33","author":"A Goyal","year":"2014","unstructured":"Goyal A, Yang B (2014) Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix. Int J Gynecol Pathol 33:613\u2013619","journal-title":"Int J Gynecol Pathol"},{"key":"3972_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.21873\/cgp.20235","volume":"17","author":"H Kim","year":"2020","unstructured":"Kim H, Yoon N, Woo HY, Lee EJ, Do SI, Na K, Kim HS (2020) Atypical mesonephric hyperplasia of the uterus harbors pathogenic mutation of kirsten rat sarcoma 2 viral oncogene homolog (KRAS) and gain of chromosome 1q. Cancer Genomics Proteomics 17:813\u2013826","journal-title":"Cancer Genomics Proteomics"},{"key":"3972_CR8","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1097\/00000478-199012000-00002","volume":"14","author":"JA Ferry","year":"1990","unstructured":"Ferry JA, Scully RE (1990) Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases. Am J Surg Pathol 14:1100\u201311","journal-title":"Am J Surg Pathol"},{"key":"3972_CR9","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/his.15136","volume":"84","author":"G Angelico","year":"2024","unstructured":"Angelico G, Salvatorelli L, Tinnirello G, Santoro A, Zannoni GF, Puzzo L, Magro G (2024) The first evidence of mismatch repair deficiency in mesonephric-like adenocarcinoma of the endometrium: clinicopathological and molecular features of a case emphasising a possible endometrioid carcinogenesis. Histopathology 84:1068\u20131070","journal-title":"Histopathology"},{"key":"3972_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/path.6217","volume":"262","author":"FK Kommoss","year":"2024","unstructured":"Kommoss FK, Lee CH, Tessier-Cloutier B, Gilks CB, Stewart CJ, von Deimling A, K\u00f6bel M (2024) Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix. J Pathol 262:4\u20139","journal-title":"J Pathol"},{"key":"3972_CR11","doi-asserted-by":"publisher","first-page":"107886","DOI":"10.1016\/j.lungcan.2024.107886","volume":"194","author":"Y Oya","year":"2024","unstructured":"Oya Y, Imaizumi K, Mitsudomi T (2024) The next-generation KRAS inhibitors\u2026What comes after sotorasib and adagrasib? Lung Cancer 194:107886","journal-title":"Lung Cancer"},{"key":"3972_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2217\/epi-2018-0195","volume":"11","author":"A Astolfi","year":"2019","unstructured":"Astolfi A, Fiore M, Melchionda F, Indio V, Bertuccio SN, Pession A (2019) BCOR involvement in cancer. Epigenomics 11:835\u2013855","journal-title":"Epigenomics"},{"key":"3972_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/GCO.0000000000000917","volume":"36","author":"M Richardson","year":"2024","unstructured":"Richardson M, Chase DM (2024) Latest advances in immuno-oncology for endometrial cancer: single-agent and combination regimens. Curr Opin Obstet Gynecol 36:1\u20138","journal-title":"Curr Opin Obstet Gynecol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03972-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-024-03972-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03972-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T07:21:57Z","timestamp":1764055317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-024-03972-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["3972"],"URL":"https:\/\/doi.org\/10.1007\/s00428-024-03972-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Catania 2, A.R.N.A.S. Garibaldi-Nesima of Catania, Palermo Street 636, 5\u201395122, Catania (protocol code 3647\/DSA, 30 December 2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}